Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS)
|Study ID||Alternative Stable ID||Type|
This pharmacogenomic study focused on the response of patients with MDD to an 8-week course of treatment with citalopram or escitalopram.
Briefly, clinical assessments and research assessments were performed at each study visit as summarized in Table 1. Many patients continued on antidepressant medication after the 8 week study.
Table 1: Study timeline and patient contacts.
|Week||Consent/Med Hx||Write Rx||SI Qx||SCID||HRS-D17||QIDSC16||CGI-I|
HRS-D17=Hamilton Rating Scale for Depression, QIDS-C16=Quick Inventory of Depressive Symptomatology, CGI-I=Clinical Global Impression-Improvement, SCID=Structured Clinical Interview for DSM-IV, ... (Show More)